Transcriptomic analysis of human non-small lung cancer cells A549 treated by one synthetic curcumin derivative MHMD

Area of Science:

• Molecular Biology
• Cancer Research
• Genomics

Background:

• Curcumin analog MHMD induces apoptosis in A549 lung cancer cells via extrinsic and intrinsic pathways.
• Specific regulatory genes and molecular mechanisms underlying MHMD's action remain unclear.

Purpose of the Study:

• To elucidate the molecular mechanisms and identify regulatory genes involved in MHMD-induced apoptosis of A549 cells.
• To analyze the transcriptomic profile of A549 cells following MHMD treatment.

Main Methods:

• RNA-sequencing (RNA-seq) was employed to analyze the transcriptomic profile of A549 cells after 48 hours of MHMD treatment.
• Bioinformatic analysis was performed to identify differentially expressed genes and enriched pathways.
• Reverse transcription polymerase chain reaction (RT-PCR) was used to validate the expression of key genes.

Main Results:

• RNA-seq analysis yielded 18,635 unigenes, with 850 genes upregulated and 855 genes downregulated in MHMD-treated A549 cells.
• Differentially expressed genes were associated with various cellular pathways, including apoptosis and non-small cell lung cancer (NSCLC) pathways.
• RT-PCR validation confirmed the altered expression of casp7, p53, tgfa, and prkar1b, supporting MHMD's role in apoptosis activation.

Conclusions:

• MHMD treatment significantly alters gene expression profiles in A549 lung cancer cells.
• The study identifies key genes and pathways involved in MHMD-induced apoptosis, providing insights into its anti-cancer mechanisms.
• MHMD demonstrates potential as a therapeutic agent for lung cancer by activating apoptotic pathways.